Cas:56824-90-9 ethyl 4-chloro-8-fluoroquinoline-3-carboxylate manufacturer & supplier

Chemical Name:ethyl 4-chloro-8-fluoroquinoline-3-carboxylate

CAS.NO:56824-90-9

Synonyms:4-chloro-8-fluoroquinoline-3-carboxylic acid ethyl ester

Molecular Formula:C₁₂H₉ClFNO₂

Molecular Weight:253.65700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:332.1ºC at 760 mmHg

Density:1.354g/cm3

Index of Refraction:1.593

PSA:39.19000

Exact Mass:253.03100

LogP:3.20400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-chloro-8-fluoroquinoline-3-carboxylic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-8-fluoroquinoline-3-carboxylic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-8-fluoroquinoline-3-carboxylic acid ethyl ester Use and application,4-chloro-8-fluoroquinoline-3-carboxylic acid ethyl ester technical grade,usp/ep/jp grade.

Related News: The chemical compound which is in the process of becoming an API from a raw material is called an intermediate. ethyl 4-chloro-8-fluoroquinoline-3-carboxylate manufacturer Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. ethyl 4-chloro-8-fluoroquinoline-3-carboxylate supplier Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. ethyl 4-chloro-8-fluoroquinoline-3-carboxylate vendor Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. ethyl 4-chloro-8-fluoroquinoline-3-carboxylate factory Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems.